<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04053153</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-46406</org_study_id>
    <nct_id>NCT04053153</nct_id>
  </id_info>
  <brief_title>Effects of Upper Airway Muscle Training on Obstructive Sleep Apnea Severity</brief_title>
  <official_title>Effects of Upper Airway Muscle Training on Obstructive Sleep Apnea Severity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asate LLC, DE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of Asate Silent Sleep Training on
      obstructive sleep apnea (OSA) severity in patients with mild to moderate OSA. The Asate
      Silent Sleep Training is a muscle strengthening program that uses exercise equipment (a
      musical instrument that is based on the didgeridoo). The equipment is connected to an
      application, which provides instruction on how to perform the strengthening exercises,
      measures the sound produced by the musical instrument, which enables the app to provide
      feedback on whether the individual should blow less or more and also tracks adherence to the
      strengthening program.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Will not be known if participant is getting the actual device or using the placebo</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea Hypopnea Index (AHI)</measure>
    <time_frame>8-12 weeks</time_frame>
    <description>Apnea Hypopnea Index during sleep</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Use of musical instrument</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Use of sham musical instrument</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Exercise equipment (a musical instrument that is based on the Medical Didgeridoo)</intervention_name>
    <description>exercise equipment (a musical instrument that is based on the Medical Didgeridoo)</description>
    <arm_group_label>Use of musical instrument</arm_group_label>
    <arm_group_label>Use of sham musical instrument</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 21 to 50

          -  Diagnosed by a physician with mild to moderate OSA, based upon interpretation of data
             recorded on a take home sleep study

          -  Body mass index &lt; 30 kg/m2

          -  Mild to moderate OSA, AHI of 5-30

        Exclusion Criteria:

          1. Apnea hypopnea index on overnight sleep study &gt; 30 per hour

          2. Currently practices didgeridoo

          3. Consumes more than 2 alcoholic beverages per day

          4. History of chronic lung disease (e.g., COPD, asthma)

          5. Oral maxillofacial issue or craniofacial musculoskeletal conditions

          6. Any treatment for OSA (current or past)

          7. Mobile device use frequency &lt; once per week

          8. Homelessness

          9. No reliable transportation to assessment sessions

         10. Planned social/family/employment obligations that would limit participant from
             engaging in Asate Silent Sleep training during the intervention period

         11. Significant upper extremity weakness/paralysis or pain limiting ability to hold the
             Medical Didgeridoo

         12. Uncorrected low vision or blindness

         13. Deafness

         14. No Internet connection/Chrome browser/mobile devices with iOS and Android

         15. No USB port in computer

         16. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clete A Kushida, MD/PhD</last_name>
    <phone>6507217560</phone>
    <email>clete@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Polina Davidenko</last_name>
    <phone>6507217552</phone>
    <email>pdaviden@stanford.edu</email>
  </overall_contact_backup>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 8, 2019</study_first_submitted>
  <study_first_submitted_qc>August 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2019</study_first_posted>
  <last_update_submitted>October 7, 2019</last_update_submitted>
  <last_update_submitted_qc>October 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Clete A. Kushida</investigator_full_name>
    <investigator_title>Division Chief/Medical Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

